A Study of LY3981314 in Healthy Participants

PHASE1RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 9, 2025

Primary Completion Date

February 28, 2027

Study Completion Date

February 28, 2027

Conditions

Healthy

Interventions

DRUG

LY3981314

Administered SC

DRUG

Placebo

Administered SC

Trial Locations (1)

RECRUITING

CenExel ACT, Anaheim

All Listed Sponsors

lead

Eli Lilly and Company

INDUSTRY

NCT07005284 - A Study of LY3981314 in Healthy Participants | Biotech Hunter | Biotech Hunter